Brimonidine (Akorn, Inc.)


Welcome to the PulseAid listing for the Brimonidine drug offered from Akorn, Inc.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Brimonidine Tartrate
SUBSTANCE NAME: BRIMONIDINE TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2006-09-07
END MARKETING DATE: 0000-00-00


Brimonidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBrimonidine from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2006-09-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-715_42f23969-7f12-43bf-af6f-d2f070dc6549
PRODUCT NDC: 17478-715
APPLICATION NUMBER: ANDA076439

Other BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Brimonidine
Allergan, Inc.ALPHAGAN P
Bausch & Lomb IncorporatedBrimonidine Tartrate
Galderma Laboratories, L.P.Mirvaso
Osmotica Pharmaceutical Corp.Brimonidine Tartrate
Pacific Pharma, Inc.BRIMONIDINE TARTRATE
Physicians Total Care, Inc.ALPHAGAN P
Regimed MedicalBrimonidine Tartrate
Sandoz IncBrimonidine Tartrate
STAT RX USA LLCBRIMONIDINE TARTRATE
Westminster Pharmaceuticals, LLCBrimonidine Tartrate Ophthalmic Solution, 0.2%